Cargando…

Angiogenesis is an independent prognostic factor in malignant mesothelioma

Angiogenesis is essential for tumour growth beyond 1 to 2 mm in diameter. The clinical relevance of angiogenesis, as assessed by microvessel density (MVD), is unclear in malignant mesothelioma (MM). Immunohistochemistry was performed on 104 archival, paraffin-embedded, surgically resected MM samples...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edwards, J G, Cox, G, Andi, A, Jones, J L, Walker, R A, Waller, D A, O'Byrne, K J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375086/ https://www.ncbi.nlm.nih.gov/pubmed/11556838 http://dx.doi.org/10.1054/bjoc.2001.1997

Ejemplares similares

Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura
por: Edwards, J G, et al.
Publicado: (2003)

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
por: O'Byrne, K J, et al.
Publicado: (2000)

Malignant mesothelioma
por: Ruffié, P, et al.
Publicado: (2001)

VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
por: Ohta, Y, et al.
Publicado: (1999)

Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis
por: Björkqvist, A-M, et al.
Publicado: (1999)

Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos
por: Magnani, C, et al.
Publicado: (2000)

High-dose methotrexate in combination with interferons in the treatment of malignant pleural mesothelioma
por: Halme, M, et al.
Publicado: (1999)

Marital status as an independent prognostic factor for patients of malignant pleural mesothelioma
por: Pan, Shu, et al.
Publicado: (2022)

p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression
por: Creaney, J, et al.
Publicado: (2001)

Hyaluronan production increases the malignant properties of mesothelioma cells
por: Li, Y, et al.
Publicado: (2001)

Expression of inducible nitric oxide synthase in healthy pleura and in malignant mesothelioma
por: Soini, Y, et al.
Publicado: (2000)

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
por: Treasure, Tom, et al.
Publicado: (2011)

The European mesothelioma epidemic
por: Peto, J, et al.
Publicado: (1999)

Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study
por: Ghanim, B, et al.
Publicado: (2015)

Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo
por: Manente, A G, et al.
Publicado: (2013)

Manganese superoxide dismutase as a diagnostic marker for malignant pleural mesothelioma
por: Kahlos, K, et al.
Publicado: (2000)

Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine
por: Propper, D J, et al.
Publicado: (2000)

Chronic immune activation and inflammation as the cause of malignancy
por: O'Byrne, K J, et al.
Publicado: (2001)

Interleukin-2 and histamine in combination inhibit tumour growth and angiogenesis in malignant glioma
por: Johansson, M, et al.
Publicado: (2000)

Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor
por: Salahshor, S, et al.
Publicado: (1999)

Curcumin induces apoptosis and inhibits angiogenesis in murine malignant mesothelioma
por: Zhang, Chengke, et al.
Publicado: (2018)

Prognostic significance of angiogenesis in human pancreatic cancer
por: Ikeda, N, et al.
Publicado: (1999)

Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma
por: Meniawy, T M, et al.
Publicado: (2013)

Long Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM)
por: Wright, Casey M., et al.
Publicado: (2013)

Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas
por: Balesaria, S, et al.
Publicado: (1999)

Vascular grading of angiogenesis: prognostic significance in breast cancer
por: Hansen, S, et al.
Publicado: (2000)

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
por: Fosså, S D, et al.
Publicado: (1999)

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey
por: Ceresoli, G L, et al.
Publicado: (2014)

Malignant mesothelioma
por: Moore, Alastair J, et al.
Publicado: (2008)

Response to comment on ‘Existing prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma'
por: Meniawy, T M, et al.
Publicado: (2014)

Analysis of prognostic factors of patients with malignant peritoneal mesothelioma
por: Yin, Wenjie, et al.
Publicado: (2018)

CD74: a new prognostic factor for patients with malignant pleural mesothelioma
por: Otterstrom, C, et al.
Publicado: (2014)

Ratio of Intratumoral Macrophage Phenotypes Is a Prognostic Factor in Epithelioid Malignant Pleural Mesothelioma
por: Cornelissen, Robin, et al.
Publicado: (2014)

Prognostic factors and the prognostic role of inflammation indices in malignant pleural mesothelioma
por: Ebinç, Senar, et al.
Publicado: (2023)

Clinical and Prognostic Features of Erionite-Induced Malignant Mesothelioma
por: Demirer, Ersin, et al.
Publicado: (2015)

Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours
por: Parliament, M B, et al.
Publicado: (2000)

Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases
por: Harvey, P, et al.
Publicado: (2000)

A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma
por: Nowak, A K, et al.
Publicado: (2002)

Angiogenesis in myelodysplastic syndromes
por: Pruneri, G, et al.
Publicado: (1999)

Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact
por: Alì, G, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_msa9hkfu6kdaqjn3edafkp15hc